home / stock / itrm / itrm news

ITRM News and Press, Iterum Therapeutics plc From 05/13/25

Stock Information
Company Name: Iterum Therapeutics plc
Stock Symbol: ITRM
Market: NASDAQ
Website: iterumtx.com
Menu
ITRM ITRM Quote ITRM Short ITRM News ITRM Articles ITRM Message Board
Get ITRM Alerts

News, Short Squeeze, Breakout and More Instantly...
ITRM - Expected US Company Earnings on Tuesday, May 13th, 2025

urban-gro Inc. (UGRO) is expected to report for quarter end 2025-03-31 Karman Holdings Inc. (KRMN) is expected to report $0.02 for Q1 2025 PyroGenesis Inc Com (PYRGF) is expected to report for quarter end 2025-03-31 GeoVax Labs Inc. (GOVX) is expected to report $-0.59 for Q1 2025 ...
ITRM - Iterum Therapeutics Reports First Quarter 2025 Financial Results

--Preparing for Potential Launch of ORLYNVAH TM by Q4 2025-- - -Extended Cash Runway into 2026-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, May 13, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a comp...

ITRM - Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025

DUBLIN, Ireland and CHICAGO, May 06, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Company), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today annou...

ITRM - Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

DUBLIN, Ireland and CHICAGO, April 30, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today...
ITRM - Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares

DUBLIN, Ireland and CHICAGO, April 29, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today...

ITRM - Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics

DUBLIN and CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that one pos...

ITRM - Iterum Therapeutics files for $150M mixed securities shelf

2025-02-07 16:40:00 ET More on Iterum Therapeutics Iterum outlines ORLYNVAH's market potential with exclusivity through 2034 Iterum Therapeutics Non-GAAP EPS of -$0.12 beats by $0.12 Seeking Alpha’s Quant Rating on Iterum Therapeutics Read the full a...
ITRM - Iterum outlines ORLYNVAH's market potential with exclusivity through 2034

2025-02-07 10:20:46 ET More on Iterum Therapeutics Iterum Therapeutics plc (ITRM) Q4 2024 Earnings Call Transcript Iterum Therapeutics plc (ITRM) Q3 2024 Earnings Call Transcript Iterum Therapeutics Non-GAAP EPS of -$0.12 beats by $0.12 Seeking Alpha’s...

ITRM - Iterum Therapeutics plc (ITRM) Q4 2024 Earnings Call Transcript

2025-02-07 10:20:15 ET Iterum Therapeutics plc (ITRM) Q4 2024 Earnings Conference Call February 07, 2025 08:30 AM ET Company Participants Louise Barrett - SVP, Legal Affairs Corey Fishman - CEO Judy Matthews - CFO Conference Call Participants Thomas Y...

ITRM - Iterum Therapeutics Non-GAAP EPS of -$0.12 beats by $0.12

2025-02-07 07:04:43 ET More on Iterum Therapeutics Iterum Therapeutics plc (ITRM) Q3 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Iterum Therapeutics Historical earnings data for Iterum Therapeutics Financial information for Iterum The...
Previous 10 Next 10